GLP Watchdog

Allara Health vs LifeMD

Neither Allara Health nor LifeMD has an FDA warning letter on record. Allara Health prices medication from $149 a month plus a required membership, so it has no all-in monthly price to set against another seller's. LifeMD starts at $298 a month for brand-name semaglutide pill.

To see where both sit among the other sellers, read our best weight-loss injection providers board.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

Allara Health / LifeMD

Allara Health logo

Allara Health

6.5/10

LifeMD logo

LifeMD

6.0/10

FDA warning letters
None on record
None on record
Pharmacy
Brand-name only; no compounding
Brand-name only; no compounding
Lowest standing price
$149/moMedication only; a membership is required on top
$298/moBrand-name semaglutide pill
States
44 states
All 50 states
Checked
Prices captured Record checked September 2026
Prices captured Record checked October 2026
Visit Allara Health
Visit LifeMD

Neither Allara Health nor LifeMD pays us. Links to them earn nothing. Scores: Allara Health 6.5, LifeMD 6.0. How we are paid

What the record shows

  1. 01

    Neither Allara Health nor LifeMD has an FDA warning letter on record.

  2. 02

    Allara Health prices medication from $149 a month plus a required membership, so it has no all-in monthly price to set against another seller's. LifeMD starts at $298 a month for brand-name semaglutide pill.

  3. 03

    Only LifeMD lists a price for brand-name semaglutide pen, brand-name tirzepatide pen and brand-name semaglutide pill.

  4. 04

    LifeMD covers six states Allara Health does not.

  5. 05

    Allara Health does not state its cancellation terms; LifeMD states you can cancel at any time.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

Allara Health

LifeMD

Brand-name semaglutide pen
Not sold or not priced

$348/mo

$4,176 a year

Brand-name tirzepatide pen
Not sold or not priced

$448/mo

$5,376 a year

Brand-name semaglutide pill
Not sold or not priced

$298/mo

$3,576 a year

Price includes
Clinician visits, coaching
Clinician visits, labs, coaching
Billed separately
Medication
Medication
Cancel any time
Not stated
Yes, stated
Minimum term
1 month
None
Refunds
Refund requests within 30 days of a charge; Allara Rx prescriptions are final sale
Money-back guarantee after 12 months if under 10% loss and all conditions met
Early-exit fee
None stated
Not stated

Read off each seller’s own pages. Allara Health: September 28, 2026. LifeMD: October 31, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for Allara Health

6.5/10

The record gives Allara Health no edge on this pair.

  • Publishes no GLP-1 price
Visit Allara Health

The case for LifeMD

6.0/10
  • Sells brand-name semaglutide pen and brand-name tirzepatide pen, which Allara Health does not price
  • Lists 50 states against 44
  • States you can cancel at any time
  • Price leaves out medication
Visit LifeMD

Scores

Allara Health 6.5 · LifeMD 6.0 out of 10. Six weighted parts.

Value25%

3.0A
vs
B
3.0

Effectiveness25%

9.0A
vs
B
10.0

User Experience15%

7.0A
vs
B
3.0

Trust & Safety15%

7.5A
vs
B
5.0

Accessibility10%

9.0A
vs
B
10.0

Support10%

4.0A
vs
B
5.5

The score is the same formula for every seller. Payment does not enter it. Method

Allara Health vs LifeMD: questions

Neither Allara Health nor LifeMD has an FDA warning letter on record. Letters are matched to a seller by company, domain and address, never by a similar name.
Allara Health does not state its cancellation terms. LifeMD states you can cancel at any time; refunds: money-back guarantee after 12 months if under 10% loss and all conditions met.
Neither Allara Health nor LifeMD pays us. Links to them earn nothing. Scores: Allara Health 6.5, LifeMD 6.0.

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Sellers closest to these two

Matched on molecule, form and price. Every pair we list · The register

Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks